Telomir Pharmaceuticals News

Telomir Pharmaceuticals | 8-K: Current report

Jun 24 15:51 ET

Telomir Pharmaceuticals | 10-Q: Quarterly report

May 13 16:36 ET

Telomir Pharmaceuticals | 8-K: Current report

Apr 15 16:21 ET

Telomir Pharmaceuticals | 8-K: Current report

Apr 12 16:09 ET

Telomir Pharmaceuticals | 10-K: FY2023 Annual Report

Mar 29 17:33 ET

Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Bay Shore Trust

Feb 15 16:15 ET

Telomir Pharmaceuticals | 8-K: Current report

Feb 13 16:32 ET

Telomir Pharmaceuticals | 424B4: Prospectus

Feb 12 15:10 ET

Telomir Pharmaceuticals | 424B1: Prospectus

Feb 12 15:09 ET

Telomir Pharmaceuticals | EFFECT: Others

Feb 9 06:04 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner Bay Shore Trust

Feb 8 18:06 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Tuck Talhia

Feb 8 18:01 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Fuentes Nathen

Feb 8 17:56 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Jerman Michael Allen

Feb 8 17:56 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director McColl Hugh III

Feb 8 17:51 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director EAGLE CRAIG

Feb 8 17:51 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Nicholoudis Christos

Feb 8 17:41 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Officer Chapman Christopher C JR

Feb 8 17:41 ET

Telomir Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Kroenig Bradley

Feb 8 17:36 ET

Telomir Pharmaceuticals | CERT: Others

Feb 8 16:32 ET